DHFR and pneumocystosis: The primary option for the treatment and prophylaxis of PCP is cotrimoxazole (trimethoprim-sulfamethoxazole, TMP-SMX), a drug combination that targets two enzymes in the folate pathway—dihydropteroate synthase (DHPS) and dihydrofolate reductase (DHFR).